YSB INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.29 HKD | 0.00% |
|
+2.60% | +0.61% |
| Sales 2022 | 14.27B 1.98B 15.44B 158B | Sales 2023 | 16.97B 2.35B 18.36B 188B | Capitalization | 4.8B 664M 5.19B 53.04B |
|---|---|---|---|---|---|
| Net income 2022 | -1.49B -206M -1.61B -16.46B | Net income 2023 | -3.19B -441M -3.45B -35.26B | EV / Sales 2022 * | - |
| Net cash position 2022 | 1.69B 233M 1.82B 18.65B | Net cash position 2023 | 1.62B 224M 1.75B 17.91B | EV / Sales 2023 | 0.19 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.91
x | Employees | 6,306 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 29.77% |
More Fundamentals
* Assessed data
More news
| 1 week | +2.60% | ||
| Current month | +2.35% | ||
| 1 month | -1.54% | ||
| 3 months | +19.28% | ||
| 6 months | -50.18% | ||
| Current year | +0.61% |
1 week
7.92
8.50
1 month
7.678.99
Current year
5.9110.98
1 year
5.9164.50
3 years
5.9164.50
5 years
5.9164.50
10 years
5.9164.50
| Managers | Title | Age | Since |
|---|---|---|---|
Bu Zhen Zhang
CEO | Chief Executive Officer | 49 | 31/12/14 |
Fei Chen
DFI | Director of Finance/CFO | 40 | 31/03/22 |
Zhuo Qi Chen
CTO | Chief Tech/Sci/R&D Officer | 45 | 26/08/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Han Hui Sun
BRD | Director/Board Member | 50 | 14/06/23 |
Rong Shao
BRD | Director/Board Member | 62 | 14/06/23 |
Bu Zhen Zhang
CEO | Chief Executive Officer | 49 | 31/12/14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 8.29 | 0.00% | 1,830,800 |
| 09/05/24 | 8.29 | +3.37% | 1,939,400 |
| 08/05/24 | 8.02 | -2.20% | 1,894,200 |
| 07/05/24 | 8.2 | -2.38% | 1,819,200 |
| 06/05/24 | 8.4 | -1.06% | 2,043,600 |
Delayed Quote Hong Kong S.E., May 10, 2024 at 09:08 am
More quotes
YSB Inc is an investment holding company mainly engaged in the provision of wholesale and retail of pharmaceuticals and healthcare products, as well as the provision of platform business services. The Company is mainly engaged in the wholesale and retail of pharmaceuticals and healthcare products on offline or online platforms. The Company provides an online platform for pharmaceutical distributors to sell their pharmaceuticals and healthcare products. The Company also provides software-as-a-service (SaaS) solutions for pharmacies, provides medical testing services for primary medical institutions, sells smart unmanned pharmaceutical booth to third-party pharmacies, as well as provides maintenance and technical support services in relation to the smart unmanned pharmaceutical booth to third-party pharmacies. The Company principally conducts its businesses in the domestic market.
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +0.61% | 680M | |
| +20.94% | 72.78B | |
| -1.26% | 24.24B | |
| +5.13% | 8.59B | |
| +8.25% | 8.38B | |
| -19.42% | 8.09B | |
| +5.56% | 4.81B | |
| +16.83% | 4.32B | |
| -1.83% | 4.05B | |
| -1.65% | 3.93B |
- Stock Market
- Equities
- 9885 Stock
